Zealand Pharma A/S (CPH:ZEAL)
Denmark · Delayed Price · Currency is DKK 424.40
+0.30 (0.07%)
At close: Jan 8, 2026
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 29.89 billion as of January 8, 2026. Its market cap has decreased by -47.30% in one year.
Market Cap
29.89B
Enterprise Value
14.13B
Revenue
9.16B
Ranking
n/a
PE Ratio
4.63
Stock Price
424.40
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 29.89B, an increase of 2,026.57%. That is a compound annual growth rate of 22.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 29.89B | -9.01% |
| Dec 30, 2025 | 32.85B | -35.01% |
| Dec 30, 2024 | 50.55B | 132.03% |
| Dec 29, 2023 | 21.79B | 110.16% |
| Dec 30, 2022 | 10.37B | 65.31% |
| Dec 30, 2021 | 6.27B | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.54T |
| Genmab | 130.34B |
| Coloplast | 122.19B |
| ALK-Abelló | 49.99B |
| Demant | 47.67B |
| H. Lundbeck | 41.05B |
| Ambu A/S | 24.02B |
| GN Store Nord | 16.66B |